ZOM: שווי שוק להכנסות Zomedica Corporation

Zomedica Corp. (ZOM) revenue dependence on TRUFORMA system sales creates certain risks, as evidenced by the historical P/S chart. The value is currently held at 3.60, reflecting veterinary confidence in diagnostic accuracy. The company's current strategy is based on organic growth and the integration of acquired IT solutions rather than new M&A deals to preserve capital.
Zomedica Corporation (ZOM) - פילוחי מדדים ודוחות פיננסיים

The ratio is calculated as market capitalization divided by total revenue, determining the value of one dollar of sales in the eyes of investors. This metric reflects the market valuation of the monetization efficiency of the Truforma and Pulsevet closed ecosystems, allowing the P/S chart of Zomedica Corp. (ZOM) to identify whether the asset is overbought or possesses growth potential amid the expansion of the veterinary clinic network.